Immune activation in HIV-infected African individuals

AIDS

Volumn 12, Issue 18, 1998, Pages 2387-2396

  Rizzardini, Giuliano ^a   Trabattoni, Daria ^a   Saresella, Marina ^a   Piconi, Stefania ^a   Lukwiya, Matthew ^b   Declich, Silvia ^c   Fabiani, Massimo ^c   Ferrante, Pasquale ^a   Clerici, Mario ^a  

^a UNIVERSITY OF MILAN   (Italy)

^b St Mary's Hospital Lacor Uganda   (Uganda)

^c ISTITUTO SUPERIORE DI SANITÀ   (Italy)

Author keywords

Africa; Cytokines; HIV; Immunology; Immunophenotype; Virology

Indexed keywords

CD4 ANTIGEN; CD8 ANTIGEN; GAMMA INTERFERON; INTERLEUKIN 10; TUMOR NECROSIS FACTOR ALPHA;

ADULT; ARTICLE; FEMALE; HELPER CELL; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNOPHENOTYPING; ITALY; MAJOR CLINICAL STUDY; MALE; MEMORY CELL; MONONUCLEAR CELL; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; UGANDA; VIREMIA;

EID: 0032564581     PISSN: 02699370     EISSN: None     Source Type: Journal    
DOI: 10.1097/00002030-199818000-00007     Document Type: Article

References (51)

1. UNAIDS: Report on the global HIV/AIDS epidemic. Geneva, 26 November 1997. www.unaids.org.
2. Colebunders RL, Ryder R, Francis H, et al.: Seroconversion rate, mortality and clinical manifestations associated with the receipt of an HIV infected blood transfusion in Kinshasa, Zaire. J Infect Dis 1991, 164:450-456.
3. N'Gali B, Ryder RW, Kapita B, et al.: HIV infection amongst employees in an African hospital. N Engl J Med 1988, 319:1123-1127.
4. Ward JW, Deppe DA, Samson S, et al.: Risk of HIV infection from blood donors who later developed AIDS. Ann Intern Med 1987, 106:61-62.
5. Mbaga JM, Pallangyo KJ, Banari M, Aris ES: Survival time of patients with AIDS: experience with 274 patients in Dar es Salaam. East Afr Med J 1990, 67:95-99.
6. Gilks CF, Otieno L, Brindle RJ, et al.: The presentation and outcome of HIV-related disease in Nairobi. Q J Med 1992, 82:25-32.
7. Bwayo JJ, Nagelkerke NJD, Moses S, et al.: Comparison of the declines in CD4 counts in HIV-1 seropositive female sex workers and women from the general population in Nairobi, Kenya. J AIDS 1995, 10:457-461.
8. Van de Perre P: The epidemiology of HIV infection and AIDS in Africa. Trends Microbiol 1995, 3:217-222.
9. Grant AD, Djomand G, Decock KM: Natural history and spectrum of disease in adults with HIV/AIDS in Africa. AIDS 1997, 11 (suppl B):S43-54.
10. Morgan D, Maide GH, Malamba SS, et al.: HIV-1 disease progression and AIDS-defining disorders in rural Uganda. Lancet 1997, 350:245-250.
11. Nunn PP, Brindle R, Carpenter L, et al.: Cohort study of HIV infection in patients with tuberculosis in Nairobi, Kenya. Analysis of early (6 month) mortality. Am Rev Resp Dis 1992, 146:849-854.
12. De Cock KM, Soro B, Coulibaly IM, Lucas SB: Tuberculosis and HIV infection in Sub-Saharan Africa JAMA 1992, 268:1581-1587.
13. Quinn TC, Piot P, McCormick JB, et al.: Serologic and immunologic studies in patients with AIDS in North America and Africa. JAMA 1987, 257:2617-2621.
14. Raviglione MC, Harries AD, Msiska R, Wilkinson D, Nunn P: Tuberculosis and HIV: current status in Africa. AIDS 1997, 11 (suppl B) S115-123.
15. STD/AIDS Control Program: Ministry of Health HIV/AIDS Surveillance Report. Entebbe, Uganda; 1997.
16. WHO/OMS: Global AIDS surveillance. WER (Weekly Epidemiologic Record) 1997, 72:357-364.
17. Asiimwe-Okiror G, Oppio AA, Musinguzi I, et al.: Change in sexual behaviour and decline in HIV infection among young pregnant women in urban Uganda. AIDS 1997, 11:1717-1763.
18. Bentwich Z, Kalindovich A, Weisman Z: Immune activation is a dominant factor in the pathogenesis of African AIDS. Immunol Today 1995, 16:187-191.
19. Rizzardini G, Piconi S, Ruzzante S, et al.: Immunologic activation markers in the serum of African and European HIV seropositive and seronegative individuals. AIDS 1996, 10:1535-1542.
20. Bentwich Z, Weisman Z, Grossman Z, Galai N, Kalinkovich A: Pathogenesis of AIDS in Africa. Lesson from the Ethiopian immigrants in Israel. The Immunologist 1997, 5:21-26.
21. Clerici M, Stocks NI, Zajac RA, et al.: IL-2 production permits detection of antigenic peptide recognition by T helper lymphocytes from asymptomatic, HIV seropositive individuals. Nature 1989, 339:383-385.
22. Anonymous: Revised CDC classification system and expanded AIDS surveillance definition for adolescents and adults. MMWR 1992, 41:RR17.
23. Bonaguro L, Del Gaudio E, Monaco M, et al.: Heteroduplex mobility assay and phylogenetic analysis of V3 region sequences of HIV-1 isolates from Gulu, Northern Uganda. J Virol 1995, 69:7971-7981.
24. Burke DS, McCutchan FE: Global distribution of human HIV-1 clades. In AIDS: Biology, Diagnosis, Treatment and prevention. Edited by Vincent T, DeVita J, Hellman S Rosenberg SA. Philadelphia: Lippincott-Raven; 1997:119-126.
25. Brennan CA, Lund Jk, Golden A, et al.: Serologic and phylogenetic characterization of HIV-1 subtypes in Uganda. AIDS 1997, 11:1823-1832.
26. Wieland U, Seelhoff A, Hofman A, et al.: Diversity of the vif gene of HIV-1 in Uganda. J Gen Virol 1997, 78:394-400.
27. Loussert-Ajaka I, Descamps D, Simon F, et al.: Genetic diversity and HIV detection by polymerase chain reaction, Lancet 1995, 346:912-913.
28. Dunne AL, Crowe SM: Comparison of branched DNA and reverse transcriptase polymerase chain reaction for quantifying six different HIV-1 subtypes in plasma [letter]. AIDS 1997, 11:126-127.
29. Kanki PI, Peeters M, Gueye-Ndiaye A: Virology of HIV-1 and HIV-2: implications for Africa. AIDS 1997, 11:S33-42.
30. Kern D, Collins M, Fultz T, et al.: An enhanced-sensitivity branched-DNA assay for quantification of human immunodeficiency virus type 1 RNA in plasma. J Clin Microbiol 1996. 34:3196-3202.
31. Coste J, Montes B, Reynes J, et al.: Effect of HIV-1 genetic diversity on HIV-1 RNA quantification in plasma: comparative evaluation of three commercial assays J AIDS 1997, 15:174-175.
32. Tarantola D, Schwartlander B: HIV/AIDS epidemics in sub-Saharan Africa: dynamism, diversity and discrete declines? AIDS 1997, 11 (suppl B):S5-21.
33. Colebunders RL , Latif AS: Natural history and clinical presentation of HIV-1 infection in adults. AIDS 1991, 5 (suppl 1): S103-112
34. Fabiani M, Blé C, Lukwiya M, et al.: HIV prevalence and trend among different risk groups in North Uganda. Tenth International Conference on AIDS and STD in Africa. Abidjan, Cote d'Ivoire. 7-11 December 1997 [Abstract C505].
35. Abbas AK, Lichtman AH, Pober JS: Cytokines. In Cellular and Molecular, Immunology, Philadelphia: WB Saunders Co.; 1995:225-244.
36. Rosenberg ZF, Fauci AS: Induction of expression of HIV in latently or chronically infected cells. AIDS Res Hum Retrovir 1989, 5:1-8.
37. Koyanagi Y, O'Brien WA, Zhao JQ, et al.: Cytokines alter production of HIV from primary mononuclear phagocytes. Science 1988, 241:1637-1641.
38. O'Brien WA, Grovit-Ferbas K, Namaze A, et al.: Human immunodeficiency virus-type 1 replication can be increased in peripheral blood of seropositive patients after influenza vaccination. Blood 1995, 3: 1082-1090
39. Staprans SI, Hamilton BL, Follansbee SE. et al.: Activation of virus replication after vaccination of HIV-1 infected individuals. J Exp Med 1995, 182: 1727-1736.
40. Stanley SK, Ostrowsky MA, Justement JS, et al.: Effect of immunization with a common recall antigen on viral expression in patients infected with human immunodeficiency virus type 1. N Engl J Med 1996, 334: 1222-1230.
41. Ramilo O, Hicks PJ, Borvak J: T cell activation and human immunodeficiency virus replication after influenza immunization of infected children. Pediatr Infect Dis J 1996, 15:197-202.
42. Viganò A, Bricalli D, Irabattoni D, et al.: Immunization with both T cell-dependent and T cell-independent vaccines augments HIV viral load secondarily to stimulation of TNF-α AIDS Res Hum Retrovir 1998, 14:725-732.
43. Mellors JW, Griffith BP, Ortis MA, Landry ML, Ryan JR: Tumor necrosis factor-α/cachectin enhances human immunodeficiency virus type 1 replication in primary macrophages J Infect Dis 1991, 163:78-84.
44. Duh IJ, Maury WJ, Folk TM, Fauci AS, Rabson AB: Tumor necrosis factor a activates human immunodeficiency virus type 1 through induction of nuclear factor binding to the NF-kB site long terminal repeat. Proc Natl Acad Sci U S A 1990, 86:5974-5979.
45. - T helper cells from normal donors and HIV-infected patients. J Immunol 1995, 154: 1408-1415.
46. Romagnani S, Del Prete G, Manetti R, et al.: Role of Th1/Th2 cytokines in HIV infection, Immunol Rev 1994, 140:73-92.
47. Mossmann TR, Coffman RI: Two types of mouse T helper cell clone: implication for immune regulation, Immunol Today 1987, 8:223-226.
48. Mossmann TR, Coffman RI: Th1 and Th2 cells: different pattern of lymphokine secretion lead to different functional properties. Annu Rev Immunol 1989, 7:145-175.
49. Chang I, Naii HM, Li S, Ilo-Shon M, Cunningham AL: The inhibition of HIV replication in monocytes by interleukin 10 is linked to inhibition of cell differentiation. AIDS Res Human Retrovir 1996, 12:1227-1235.
50. Naif HM, Chang J, Ho-Shon M, Li S, Cunningham AL: Inhibition of human immunodeficiency virus replication in differentiating monocytes by interleukin 10 occurs in parallel with inhibition of cellular RNA expression. AIDS Res Human Retrovir 1996, 12:1237-1245.
51. Romano MF, Lamberti A, Petrella A, et al.: IL-10 inhibits nuclear factor-kappa B/Rel nuclear activity in CD3-stimulated human peripheral T lymphocytes, J Immunol 1996, 156:2119-2123.